Levamisole as adjuvant therapy for melanoma: quo vadis?
Parkinson
D R
DR
D001500:BCG Vaccine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D006801:Humans; D007978:Levamisole / Q000627:therapeutic use*; D008545:Melanoma / Q000628:therapy*
D001500:BCG Vaccine; D007978:Levamisole